An Open Study To Estimate The Plasma Pharmacokinetics Of PF-00241939 Administered Via Oral Inhalation Using Dry Powder Inhalers.
Phase of Trial: Phase I
Latest Information Update: 21 Jan 2011
At a glance
- Drugs PF 241939 (Primary)
- Indications Asthma
- Focus Pharmacokinetics
- 21 Jan 2011 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 21 Jan 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
- 21 Jan 2011 Actual initiation date (Oct 2010) added as reported by ClinicalTrials.gov.